82 related articles for article (PubMed ID: 14600778)
1. Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions.
Kim YK; Lee JM; Kim CS
Eur Radiol; 2004 Jan; 14(1):5-13. PubMed ID: 14600778
[TBL] [Abstract][Full Text] [Related]
2. Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma.
Reizine E; Ronot M; Ghosn M; Calderaro J; Frulio N; Bioulac-Sage P; Trillaud H; Vilgrain V; Paradis V; Luciani A
Eur Radiol; 2021 May; 31(5):3417-3426. PubMed ID: 33146794
[TBL] [Abstract][Full Text] [Related]
3. Atypical Enhancement of Gd-BOPTA on the Hepatobiliary Phase in Hepatic Metastasis from Carcinoid Tumor - Case Report.
Pozowski P; Misiak P; Szymańska K; Mazur R; Sierpowska M; Silicki J; Celmer M; Łasecki M; Pawluś A; Zaleska-Dorobisz U
Am J Case Rep; 2020 Sep; 21():e924280. PubMed ID: 32883944
[TBL] [Abstract][Full Text] [Related]
4. Detection of liver metastases on gadobenate dimeglumine-enhanced MRI: systematic review, meta-analysis, and similarities with gadoxetate-enhanced MRI.
Zhang L; Yu X; Huo L; Lu L; Pan X; Jia N; Fan X; Morana G; Grazioli L; Schneider G
Eur Radiol; 2019 Oct; 29(10):5205-5216. PubMed ID: 30915560
[TBL] [Abstract][Full Text] [Related]
5. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study.
Nowicki TK; Markiet K; Izycka-Swieszewska E; Dziadziuszko K; Studniarek M; Szurowska E
BMC Gastroenterol; 2018 Jan; 18(1):10. PubMed ID: 29334905
[TBL] [Abstract][Full Text] [Related]
6. Malignant focal liver lesions at contrast-enhanced ultrasonography and magnetic resonance with hepatospecific contrast agent.
D'Onofrio M; Crosara S; De Robertis R; Canestrini S; Cantisani V; Morana G; Mucelli RP
Ultrasound; 2014 May; 22(2):91-8. PubMed ID: 27433201
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases.
Beiderwellen K; Geraldo L; Ruhlmann V; Heusch P; Gomez B; Nensa F; Umutlu L; Lauenstein TC
PLoS One; 2015; 10(9):e0137285. PubMed ID: 26335246
[TBL] [Abstract][Full Text] [Related]
8. Low-dose gadobenate dimeglumine-enhanced MRI of the kidney for the differential diagnosis of localized renal lesions.
Schneider G; Probst T; Kirchin MA; Stroeder J; Fries P; Buecker A
Radiol Med; 2015 Dec; 120(12):1100-11. PubMed ID: 26088468
[TBL] [Abstract][Full Text] [Related]
9. Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver.
Inchingolo R; De Gaetano AM; Curione D; Ciresa M; Miele L; Pompili M; Vecchio FM; Giuliante F; Bonomo L
Eur Radiol; 2015 Apr; 25(4):1087-96. PubMed ID: 25430005
[TBL] [Abstract][Full Text] [Related]
10. Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.
Thian YL; Riddell AM; Koh DM
Cancer Imaging; 2013 Dec; 13(4):567-79. PubMed ID: 24434892
[TBL] [Abstract][Full Text] [Related]
11. Gd-EOB-DTPA-Enhanced MRI for Detection of Liver Metastases from Colorectal Cancer: A Surgeon's Perspective!
Lafaro KJ; Roumanis P; Demirjian AN; Lall C; Imagawa DK
Int J Hepatol; 2013; 2013():572307. PubMed ID: 23653860
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases: comparison with multidetector-row CT.
Kim YK; Park G; Kim CS; Yu HC; Han YM
Br J Radiol; 2012 May; 85(1013):539-47. PubMed ID: 22556405
[TBL] [Abstract][Full Text] [Related]
13. Hepatobiliary MR imaging with gadolinium-based contrast agents.
Frydrychowicz A; Lubner MG; Brown JJ; Merkle EM; Nagle SK; Rofsky NM; Reeder SB
J Magn Reson Imaging; 2012 Mar; 35(3):492-511. PubMed ID: 22334493
[TBL] [Abstract][Full Text] [Related]
14. Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians.
Chanyaputhipong J; Low SC; Chow PK
Int J Hepatol; 2011; 2011():489342. PubMed ID: 21994860
[TBL] [Abstract][Full Text] [Related]
15. Differentiating focal eosinophilic infiltration from metastasis in the liver with gadoxetic acid-enhanced magnetic resonance imaging.
Lee MH; Kim SH; Kim H; Lee MW; Lee WJ
Korean J Radiol; 2011; 12(4):439-49. PubMed ID: 21852904
[TBL] [Abstract][Full Text] [Related]
16. Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid.
Frydrychowicz A; Nagle SK; D'Souza SL; Vigen KK; Reeder SB
J Magn Reson Imaging; 2011 Sep; 34(3):585-94. PubMed ID: 21751288
[TBL] [Abstract][Full Text] [Related]
17. Is hepatotropic contrast enhanced MR a more effective method in differential diagnosis of hemangioma than multi-phase CT and unenhanced MR?
Szurowska E; Nowicki T; Izycka-Swieszewska E; Wypych J; Drobinska-Jurowiecka A; Markiet K; Szarmach A; Studniarek M
BMC Gastroenterol; 2011 Apr; 11():43. PubMed ID: 21504593
[TBL] [Abstract][Full Text] [Related]
18. Solid focal liver lesions: dynamic and late enhancement patterns with the dual phase contrast agent gadobenate dimeglumine.
Grazioli L; Bondioni MP; Faccioli N; Gambarini S; Tinti R; Schneider G; Kirchin M
J Gastrointest Cancer; 2010 Dec; 41(4):221-32. PubMed ID: 20405242
[TBL] [Abstract][Full Text] [Related]
19. Hypointense hepatic lesions depicted on gadobenate dimeglumine-enhanced three-hour delayed hepatobiliary-phase MR imaging: differentiation between benignancy and malignancy.
Hwang HS; Kim SH; Jeon TY; Choi D; Lee WJ; Lim HK
Korean J Radiol; 2009; 10(3):294-302. PubMed ID: 19412518
[TBL] [Abstract][Full Text] [Related]
20. Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI?
Kim H; Park MS; Choi JY; Park YN; Kim MJ; Kim KS; Choi JS; Han KH; Kim E; Kim KW
Eur Radiol; 2009 Jul; 19(7):1744-51. PubMed ID: 19247666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
